Optic Neuritis Iris Ben-Bassat Mizrachi MD Jonathan D. Trobe MD I. OVERVIEW The treatment of optic neuritis has been explored in several randomized clinical trials (RCTs).1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20 In the Optic Neuritis…
Retinopathy of Prematurity (ROP) Emmanuel Chang MD, PhD Antonio Capone MD 1st edition contributions from Anna Ells, MD, FRCS (C). Introduction and Background of Retinopathy of Prematurity Retinopathy of prematurity…
Evidence-Based Medicine: The Prophylaxis and Treatment of Endophthalmitis Seenu M. Hariprasad MD William F. Mieler MD In spite of significant advances in the management of endophthalmitis over the past two…
Arterial Occlusive Disease Jason Noble MD, FRCSC, DABO, Mark O. Baerlocher MD, FRCPC Background Although atherosclerotic vascular disease is primarily appreciated as the major contributor to systemic morbidity and mortality…
Retinal Vein Occlusions (Evidence-Based Eye Care) Paul Hahn MD, PhD Sharon Fekrat MD, FACS Introduction Retinal vein occlusion (RVO), including both branch retinal vein occlusion (BRVO) and central retinal vein…
Evidence-Based Ophthalmology: Clinical Trials and Beyond Retinal Detachment and Proliferative Vitreoretinopathy T. Mark Johnson MD FRCSC I. INTRODUCTION The management of rhegmatogenous retinal detachment has evolved over the last century…
Clinical Trials in Wet Age-Related Macular Degeneration Stephen A. McNutt MD Peter K. Kaiser MD Age-related macular degeneration (AMD) remains the leading cause of blindness in the developed world and…
Proliferative Diabetic Retinopathy: Clinical Trials Dean Eliott MD I. DIABETIC RETINOPATHY STUDY Introduction Eyes that develop proliferative diabetic retinopathy (PDR) have at least a 50% probability of becoming blind within…
Clinical Trials in Nonneovascular Age-Related Macular Degeneration Benjamin Nicholson MD Emily Y. Chew MD Age-related macular degeneration (AMD) is the leading cause of blindness in the developed world.1,2 There are…
